Drug resistance proteins, MORN repeat-containing 1 (MORN1) | | length=358 Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 4 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 2, no: 38 |
NetGPI | no | yes: 0, no: 40 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 2 |
GO:0031514 | motile cilium | 5 | 2 |
GO:0042995 | cell projection | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 2 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005815 | microtubule organizing center | 2 | 1 |
GO:0005816 | spindle pole body | 3 | 1 |
GO:0036064 | ciliary basal body | 3 | 1 |
GO:0044732 | mitotic spindle pole body | 4 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A0A3S7X3U7
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 1 |
GO:0006897 | endocytosis | 5 | 1 |
GO:0016192 | vesicle-mediated transport | 4 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016310 | phosphorylation | 5 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016301 | kinase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 172 | 176 | PF00656 | 0.267 |
CLV_C14_Caspase3-7 | 333 | 337 | PF00656 | 0.333 |
CLV_C14_Caspase3-7 | 42 | 46 | PF00656 | 0.395 |
CLV_C14_Caspase3-7 | 88 | 92 | PF00656 | 0.356 |
CLV_C14_Caspase3-7 | 98 | 102 | PF00656 | 0.266 |
CLV_NRD_NRD_1 | 292 | 294 | PF00675 | 0.323 |
CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.292 |
CLV_PCSK_KEX2_1 | 292 | 294 | PF00082 | 0.330 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.328 |
CLV_PCSK_PC1ET2_1 | 126 | 128 | PF00082 | 0.296 |
CLV_PCSK_PC1ET2_1 | 34 | 36 | PF00082 | 0.310 |
CLV_PCSK_SKI1_1 | 273 | 277 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 321 | 325 | PF00082 | 0.429 |
DOC_ANK_TNKS_1 | 291 | 298 | PF00023 | 0.390 |
DOC_MAPK_gen_1 | 315 | 324 | PF00069 | 0.429 |
DOC_PP2B_LxvP_1 | 299 | 302 | PF13499 | 0.296 |
DOC_USP7_MATH_1 | 138 | 142 | PF00917 | 0.456 |
DOC_USP7_MATH_1 | 302 | 306 | PF00917 | 0.319 |
DOC_USP7_MATH_1 | 44 | 48 | PF00917 | 0.330 |
DOC_USP7_UBL2_3 | 126 | 130 | PF12436 | 0.282 |
DOC_USP7_UBL2_3 | 177 | 181 | PF12436 | 0.366 |
DOC_USP7_UBL2_3 | 57 | 61 | PF12436 | 0.337 |
LIG_BRCT_BRCA1_1 | 142 | 146 | PF00533 | 0.326 |
LIG_deltaCOP1_diTrp_1 | 75 | 78 | PF00928 | 0.330 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.441 |
LIG_FHA_1 | 225 | 231 | PF00498 | 0.441 |
LIG_FHA_2 | 331 | 337 | PF00498 | 0.313 |
LIG_FHA_2 | 40 | 46 | PF00498 | 0.356 |
LIG_Integrin_isoDGR_2 | 82 | 84 | PF01839 | 0.312 |
LIG_LIR_Apic_2 | 132 | 138 | PF02991 | 0.361 |
LIG_LIR_Apic_2 | 183 | 187 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 213 | 218 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.296 |
LIG_Pex14_1 | 158 | 162 | PF04695 | 0.343 |
LIG_Pex14_2 | 146 | 150 | PF04695 | 0.228 |
LIG_Pex14_2 | 330 | 334 | PF04695 | 0.312 |
LIG_PTB_Phospho_1 | 352 | 358 | PF10480 | 0.493 |
LIG_SH2_CRK | 204 | 208 | PF00017 | 0.307 |
LIG_SH2_GRB2like | 112 | 115 | PF00017 | 0.275 |
LIG_SH2_GRB2like | 209 | 212 | PF00017 | 0.276 |
LIG_SH2_GRB2like | 255 | 258 | PF00017 | 0.296 |
LIG_SH2_GRB2like | 278 | 281 | PF00017 | 0.296 |
LIG_SH2_PTP2 | 184 | 187 | PF00017 | 0.307 |
LIG_SH2_SRC | 163 | 166 | PF00017 | 0.296 |
LIG_SH2_SRC | 209 | 212 | PF00017 | 0.306 |
LIG_SH2_SRC | 278 | 281 | PF00017 | 0.312 |
LIG_SH2_SRC | 43 | 46 | PF00017 | 0.315 |
LIG_SH2_SRC | 89 | 92 | PF00017 | 0.431 |
LIG_SH2_STAT5 | 184 | 187 | PF00017 | 0.319 |
LIG_SH2_STAT5 | 209 | 212 | PF00017 | 0.288 |
LIG_SH2_STAT5 | 232 | 235 | PF00017 | 0.354 |
LIG_SH2_STAT5 | 238 | 241 | PF00017 | 0.342 |
LIG_SH2_STAT5 | 3 | 6 | PF00017 | 0.390 |
LIG_SH2_STAT5 | 346 | 349 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.377 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.424 |
MOD_CK2_1 | 302 | 308 | PF00069 | 0.296 |
MOD_Cter_Amidation | 244 | 247 | PF01082 | 0.296 |
MOD_Cter_Amidation | 313 | 316 | PF01082 | 0.291 |
MOD_Cter_Amidation | 32 | 35 | PF01082 | 0.312 |
MOD_GlcNHglycan | 268 | 271 | PF01048 | 0.323 |
MOD_GlcNHglycan | 67 | 70 | PF01048 | 0.334 |
MOD_GSK3_1 | 224 | 231 | PF00069 | 0.362 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.377 |
MOD_GSK3_1 | 70 | 77 | PF00069 | 0.371 |
MOD_N-GLC_1 | 266 | 271 | PF02516 | 0.335 |
MOD_N-GLC_2 | 280 | 282 | PF02516 | 0.296 |
MOD_NEK2_1 | 253 | 258 | PF00069 | 0.294 |
MOD_NEK2_1 | 330 | 335 | PF00069 | 0.356 |
MOD_NEK2_2 | 60 | 65 | PF00069 | 0.330 |
MOD_PKA_2 | 236 | 242 | PF00069 | 0.459 |
MOD_PKA_2 | 249 | 255 | PF00069 | 0.351 |
MOD_PKA_2 | 70 | 76 | PF00069 | 0.388 |
MOD_PKA_2 | 83 | 89 | PF00069 | 0.393 |
MOD_Plk_1 | 74 | 80 | PF00069 | 0.340 |
MOD_Plk_2-3 | 303 | 309 | PF00069 | 0.302 |
MOD_Plk_4 | 180 | 186 | PF00069 | 0.299 |
MOD_Plk_4 | 205 | 211 | PF00069 | 0.371 |
MOD_Plk_4 | 228 | 234 | PF00069 | 0.382 |
MOD_SUMO_rev_2 | 170 | 178 | PF00179 | 0.348 |
MOD_SUMO_rev_2 | 216 | 224 | PF00179 | 0.390 |
MOD_SUMO_rev_2 | 50 | 58 | PF00179 | 0.297 |
TRG_DiLeu_BaEn_1 | 296 | 301 | PF01217 | 0.432 |
TRG_ENDOCYTIC_2 | 204 | 207 | PF00928 | 0.334 |
TRG_ER_diArg_1 | 319 | 322 | PF00400 | 0.408 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IIK8 | Leptomonas seymouri | 95% | 100% |
A0A0N1PBP4 | Leptomonas seymouri | 28% | 100% |
A0A0S4IT41 | Bodo saltans | 25% | 100% |
A0A0S4J443 | Bodo saltans | 27% | 81% |
A0A0S4JES9 | Bodo saltans | 27% | 71% |
A0A0S4JF26 | Bodo saltans | 30% | 100% |
A0A0S4JFV2 | Bodo saltans | 29% | 82% |
A0A0S4KIY0 | Bodo saltans | 81% | 100% |
A0A0S4KKM9 | Bodo saltans | 28% | 67% |
A0A1X0NTG8 | Trypanosomatidae | 36% | 82% |
A0A1X0P1A5 | Trypanosomatidae | 78% | 100% |
A0A1X0P3N0 | Trypanosomatidae | 25% | 100% |
A0A3R7M394 | Trypanosoma rangeli | 27% | 100% |
A0A3R7NAK8 | Trypanosoma rangeli | 37% | 87% |
A0A3S7WVR3 | Leishmania donovani | 31% | 81% |
A0A3S7WXA1 | Leishmania donovani | 36% | 68% |
A0A3S7XBA2 | Leishmania donovani | 28% | 100% |
A0A422P0W0 | Trypanosoma rangeli | 78% | 100% |
A4H3Q9 | Leishmania braziliensis | 29% | 100% |
A4HCH7 | Leishmania braziliensis | 37% | 100% |
A4HIR9 | Leishmania braziliensis | 96% | 100% |
A4HPP6 | Leishmania braziliensis | 28% | 100% |
A4HYK3 | Leishmania infantum | 31% | 81% |
A4HZZ9 | Leishmania infantum | 36% | 68% |
A4I615 | Leishmania infantum | 100% | 100% |
A4ID18 | Leishmania infantum | 27% | 100% |
C9ZRE1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 77% | 100% |
C9ZSQ2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 82% |
D0A8G8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 100% |
E9ATG0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9AVX2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 100% |
E9B1A6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 99% | 100% |
Q4Q137 | Leishmania major | 28% | 100% |
Q4Q6V8 | Leishmania major | 99% | 100% |
Q4QBK7 | Leishmania major | 36% | 100% |
Q4QD31 | Leishmania major | 30% | 81% |
V5AUB0 | Trypanosoma cruzi | 30% | 100% |
V5B9Q7 | Trypanosoma cruzi | 29% | 69% |
V5BX28 | Trypanosoma cruzi | 76% | 100% |